Navigation Links
Indian Ayurveda in troubled waters abroad.

Ayurvedic medicines exported from India to Canada have run in troubled waters. An alert has been sounded on 18 types of Ayurvedic medicines by the Canadian government. //

The action has been taken because the samples which were tested contained heavy metals like lead, mercury, arsenic much beyond the permissible limits.

The reason was that most of the medicines did not have labels declaring the presence of those heavy metals. The probe was done by the Canadian government’s health department. The findings are present in Journal of the American Medical Association.

The reason attributed to the presence of these heavy metals in the medicines is pollution of soil and water. The names of the medicines found to contain high content of heavy metals were Mahayogaraj Guggulu with silver and Makardhwaj (Baidyanath), Mahalaxmi Vilas with gold (Baidyanath), Navratna Rasa (Unjha Pharmacy) and Swarna Mahayograj Gugglu with gold (Baidyanath). Products of big companies like Dabur and Zandu are also on the caution list.

It has been mentioned in the Drugs and Cosmetic Rules 1954, prevalent in India, that labels on medicines should mention all the ingredients. As per Rule 161, medicines containing poisonous substances like mercury, arsenic and red oxide of lead have to carry a warning.

In order to pose a solution the government is making mandatory for testing of all herbal medicines, including Ayurvedic, Unani and Siddha from January 1, 2006. Every licensed manufacturer of herbal products in the country will have to declare the content of heavy metals on the containers before exports.


'"/>




Page: 1

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... American adults with chronic conditions reported skipping doses or not filling a prescription ... uninsured or under-insured, rates of cost-related problems getting medications were 30-60%*. ...
(Date:2/22/2017)... PA (PRWEB) , ... February 22, 2017 , ... Sideline ... where the company met national TV host Tom Seay and his production crew. ... a favorite among equestrians around the world. Saddle Sidekicks will be featured on ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever National Heart ... advocates, and individuals join together to increase recognition about the risks of heart ... , “Today we mark a nationwide movement to raise awareness about a disease ...
(Date:2/22/2017)... MADISON HEIGHTS, MICHIGAN (PRWEB) , ... February 22, ... ... news and analysis of issues related to spine practices, is featuring Michigan neurosurgeon ... Jagannathan is known as one of a small number of neurosurgeons in Michigan ...
(Date:2/22/2017)... ... 22, 2017 , ... Michael J. Hennessy Associates, Inc. (MJH ... technology professionals and other key stakeholders with an array of valuable resources, Healthcare ... 1, announced Michael J. Hennessy, Jr., president of MJH Associates. , In ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 22, 2017 Research and Markets has ... Market (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By ... ... is forecasted to grow at a CAGR of 5.33% during 2016-2021 ... of infectious diseases along with surging demand of digital thermometer. Apart ...
(Date:2/22/2017)... Oncternal Therapeutics, Inc., a clinical-stage biotechnology ... common malignancies, today announced the closing of an ... to use the proceeds to further clinical development ... preclinical development of a new ROR1-targeted antibody-drug conjugate ... anti-ROR1 monoclonal antibody being developed to treat patients ...
(Date:2/22/2017)... , Feb. 22, 2017 Kineta, ... development of novel immune modulating therapies, today announced ... a9a10 nicotinic acetylcholine receptor (nAChR), demonstrates robust chronic ... pain models. The study also establishes the a9a10 ... treatment of chronic pain. The findings were reported ...
Breaking Medicine Technology: